Literature DB >> 2833496

Plasma cholesteryl ester transfer protein has binding sites for neutral lipids and phospholipids.

T L Swenson1, R W Brocia, A R Tall.   

Abstract

The plasma cholesteryl ester-transfer protein (CETP, Mr 74,000) promotes exchange of both neutral lipids and phospholipids (phosphatidylcholine, PC) between lipoproteins. To investigate the mechanism of facilitated lipid transfer, CETP was incubated with unilamellar egg PC vesicles containing small amounts of cholesteryl ester (CE) or triglyceride, and then analyzed by gel filtration chromatography. There was rapid transfer of radiolabeled CE or triglyceride and PC from vesicles to CETP. The CETP with bound lipids was isolated and incubated with low density lipoproteins (LDL), resulting in transfer of the lipids to LDL. The CETP bound up to 0.9 mol of CE or 0.2 mol of triglyceride and 11 mol of PC/mol of CETP. para-Chloromercuriphenylsulfonate, an inhibitor of CE and triglyceride transfer, was found to decrease the binding of radiolabeled CE and triglyceride by CETP. Under various conditions the CETP eluted either as an apparent monomer with bound lipid (Mr 75,000-93,000), or in complexes with vesicles. The distribution of CETP between these two states was influenced by the presence of apoA-I or albumin, incubation time, vesicle/CETP ratio, and buffer pH and ionic strength. The results indicate that the CETP has binding sites for CE, triglyceride, and PC which readily equilibrate with lipoprotein lipids and suggest that CETP can act as a carrier of lipid between lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2833496

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Interaction of lipid transfer protein with plasma lipoproteins and cell membranes.

Authors:  R E Morton
Journal:  Experientia       Date:  1990-06-15

2.  Modification of CETP function by changing its substrate preference: a new paradigm for CETP drug design.

Authors:  Richard E Morton; Lahoucine Izem
Journal:  J Lipid Res       Date:  2015-01-23       Impact factor: 5.922

3.  Structural basis of transfer between lipoproteins by cholesteryl ester transfer protein.

Authors:  Lei Zhang; Feng Yan; Shengli Zhang; Dongsheng Lei; M Arthur Charles; Giorgio Cavigiolio; Michael Oda; Ronald M Krauss; Karl H Weisgraber; Kerry-Anne Rye; Henry J Pownall; Xiayang Qiu; Gang Ren
Journal:  Nat Chem Biol       Date:  2012-02-19       Impact factor: 15.040

Review 4.  Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk.

Authors:  Philip J Barter; Kerry-Anne Rye
Journal:  J Lipid Res       Date:  2012-05-22       Impact factor: 5.922

5.  Model of human low-density lipoprotein and bound receptor based on cryoEM.

Authors:  Gang Ren; Gabby Rudenko; Steven J Ludtke; Johann Deisenhofer; Wah Chiu; Henry J Pownall
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-28       Impact factor: 11.205

6.  Cholesteryl ester analogs inhibit cholesteryl ester but not triglyceride transfer catalyzed by the plasma cholesteryl ester-triglyceride transfer protein.

Authors:  S J Busch; J A Harmony
Journal:  Lipids       Date:  1990-04       Impact factor: 1.880

7.  A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins.

Authors:  K Takahashi; X C Jiang; N Sakai; S Yamashita; K Hirano; H Bujo; H Yamazaki; J Kusunoki; T Miura; P Kussie
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

8.  Mechanism of inhibition defines CETP activity: a mathematical model for CETP in vitro.

Authors:  Laura K Potter; Dennis L Sprecher; Max C Walker; Frank L Tobin
Journal:  J Lipid Res       Date:  2009-03-11       Impact factor: 5.922

9.  Cyclosporine binds to the neutral lipid and potentially other binding sites of lipid transfer protein I.

Authors:  Mona Kwong; Kishor M Wasan
Journal:  Pharm Res       Date:  2003-07       Impact factor: 4.200

10.  Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody. Effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma.

Authors:  F T Yen; R J Deckelbaum; C J Mann; Y L Marcel; R W Milne; A R Tall
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.